The real-time blood glucose continuous glucose monitoring (cgm) patch market size has grown rapidly in recent years. It will grow from $7.04 billion in 2025 to $8.08 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to increasing diabetes prevalence, rising awareness of glucose self-monitoring, growing adoption of wearable medical devices, expanding hospital-based diabetes management, improving sensor accuracy.
The real-time blood glucose continuous glucose monitoring (cgm) patch market size is expected to see rapid growth in the next few years. It will grow to $13.89 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to integration of real-time data analytics, increasing telehealth adoption, demand for personalized diabetes management, expansion of homecare diagnostics, rising investment in continuous monitoring technologies. Major trends in the forecast period include rising adoption of patch-based glucose monitoring, growing demand for real-time glucose visibility, shift toward non-invasive and minimally invasive monitoring, expansion of home-based diabetes management, increased use of continuous monitoring in early diagnosis.
The rising prevalence of diabetes is expected to drive the growth of the real-time blood glucose continuous glucose monitoring (CGM) patch market. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to insufficient insulin production or insulin resistance. Its prevalence is increasing as rising obesity rates lead to higher insulin resistance, disrupting blood sugar regulation and significantly increasing the risk of developing type 2 diabetes. Real-time blood glucose CGM patches enable people with diabetes to continuously monitor glucose levels, providing timely alerts for hyperglycemia or hypoglycemia, supporting informed dietary, medication, and lifestyle decisions, and improving overall disease management while reducing complication risks. For example, in June 2024, the National Health Service in the UK reported that in 2023, over 549,000 additional individuals in England were identified at risk of type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia or prediabetes registered with a GP to 3,615,330, up nearly 20% from 3,065,825 in 2022. This demonstrates how the rising prevalence of diabetes is driving market growth.
Key companies in the real-time blood glucose CGM patch market are focusing on innovative products such as over-the-counter continuous glucose monitoring sensors to increase access and convenience. Over-the-counter CGM sensors are wearable devices that track glucose levels in real time without a prescription, enabling users to continuously monitor glucose, understand lifestyle impacts, and manage or prevent diabetes more easily. For instance, in September 2024, Dexcom Inc., a US-based diabetes technology company, launched Stelo, its first OTC CGM patch in the United States. The small, wearable sensor attaches to the back of the upper arm and provides real-time glucose readings directly to a smartphone app without fingersticks. Designed for people with type 2 diabetes not using insulin and those with prediabetes, Stelo delivers personalized insights on how diet, exercise, and sleep affect glucose levels. The device offers up to 15-day wear, waterproofing, spike and pattern detection, and integrates with Dexcom’s glucose sensing technology, making continuous glucose monitoring more accessible and actionable for a wider population.
In January 2024, Trinity Biotech plc, an Ireland-based diagnostics company, acquired the biosensor and CGM assets of Waveform Technologies Inc. for $12.5 million in cash and 9 million ADSs. This acquisition enables Trinity Biotech to enter the growing biosensor and CGM market by leveraging Waveform’s needle-free CGM technology to develop next-generation wearable biosensors, target additional biomarkers, and promote broader global adoption of affordable diabetes care tools. Waveform Technologies Inc. is a US-based company specializing in real-time blood glucose CGM patch technology.
Major companies operating in the real-time blood glucose continuous glucose monitoring (cgm) patch market are Abbott Laboratories, Dexcom Inc., Medtronic plc, Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., MicroTech Medical Inc., Zhejiang POCTech Co. Ltd., SiBio Technology Co. Ltd., Metronom Health Inc., Nemaura Medical Inc., PKvitality SAS, Nutromics Ltd., EOFlow Co. Ltd., i-SENS Inc., Sinocare Inc., Afon Technology Ltd., LifePlus Inc., Ultrahuman Healthcare Pvt. Ltd., Roche Diabetes Care AG, Ascensia Diabetes Care Holdings AG.
North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time blood glucose continuous glucose monitoring (cgm) patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the real-time blood glucose continuous glucose monitoring (cgm) patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have introduced cost pressures and supply chain disruptions in the real-time blood glucose continuous glucose monitoring (CGM) patch market by increasing the prices of electronic components, biosensors, and wireless modules sourced from international suppliers. These cost increases have particularly affected wearable and implantable CGM patch manufacturers, with Asia-Pacific manufacturing hubs such as China and South Korea and high-consumption regions such as North America being most impacted. Distribution channels such as hospital pharmacies and online pharmacies have also faced pricing volatility due to higher import duties. However, tariffs have encouraged regional manufacturing, supplier diversification, and localized production, which is strengthening supply chain resilience and supporting long-term market stability.
The real-time blood glucose continuous glucose monitoring (cgm) patch market research report is one of a series of new reports that provides real-time blood glucose continuous glucose monitoring (cgm) patch market statistics, including real-time blood glucose continuous glucose monitoring (cgm) patch industry global market size, regional shares, competitors with a real-time blood glucose continuous glucose monitoring (cgm) patch market share, detailed real-time blood glucose continuous glucose monitoring (cgm) patch market segments, market trends and opportunities, and any further data you may need to thrive in the real-time blood glucose continuous glucose monitoring (cgm) patch industry. This real-time blood glucose continuous glucose monitoring (cgm) patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A real-time blood glucose continuous glucose monitoring (CGM) patch is a wearable device that continuously monitors glucose levels in the interstitial fluid beneath the skin. It transmits glucose readings in real time to a connected display or mobile device, enabling continuous tracking of glucose trends. The patch functions through a small sensor and transmitter that provide frequent data updates without requiring fingerstick measurements.
The primary product types of real-time blood glucose continuous glucose monitoring (CGM) patches are wearable CGM patches and implantable CGM patches. A wearable CGM patch is a discreet, skin-worn sensor that continuously tracks glucose levels and transmits real-time data to support management of diet, activity, and medication. These patches incorporate various technologies, including enzymatic and non-enzymatic systems, and are distributed through channels such as online pharmacies, retail pharmacies, hospital pharmacies, and other outlets. They are used for applications including type 1 diabetes, type 2 diabetes, gestational diabetes, and other conditions, and are utilized by hospitals, clinics, homecare settings, diagnostic centers, and other end-users.
The real-time blood glucose continuous glucose monitoring (CGM) patch market consists of revenues earned by entities by providing services such as remote patient monitoring and telehealth support, subscription and replacement programs, distribution and logistics management, clinical and diagnostic glucose monitoring services, research and development for sensor innovation, customer training and technical support, and reimbursement or healthcare partnership services. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time blood glucose continuous glucose monitoring (CGM) patch market also includes sales of microneedles paper-type biodegradable sensor, disposable patch sensor, and adhesive-backed sensor. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The real-time blood glucose continuous glucose monitoring (cgm) patch market size is expected to see rapid growth in the next few years. It will grow to $13.89 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to integration of real-time data analytics, increasing telehealth adoption, demand for personalized diabetes management, expansion of homecare diagnostics, rising investment in continuous monitoring technologies. Major trends in the forecast period include rising adoption of patch-based glucose monitoring, growing demand for real-time glucose visibility, shift toward non-invasive and minimally invasive monitoring, expansion of home-based diabetes management, increased use of continuous monitoring in early diagnosis.
The rising prevalence of diabetes is expected to drive the growth of the real-time blood glucose continuous glucose monitoring (CGM) patch market. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to insufficient insulin production or insulin resistance. Its prevalence is increasing as rising obesity rates lead to higher insulin resistance, disrupting blood sugar regulation and significantly increasing the risk of developing type 2 diabetes. Real-time blood glucose CGM patches enable people with diabetes to continuously monitor glucose levels, providing timely alerts for hyperglycemia or hypoglycemia, supporting informed dietary, medication, and lifestyle decisions, and improving overall disease management while reducing complication risks. For example, in June 2024, the National Health Service in the UK reported that in 2023, over 549,000 additional individuals in England were identified at risk of type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia or prediabetes registered with a GP to 3,615,330, up nearly 20% from 3,065,825 in 2022. This demonstrates how the rising prevalence of diabetes is driving market growth.
Key companies in the real-time blood glucose CGM patch market are focusing on innovative products such as over-the-counter continuous glucose monitoring sensors to increase access and convenience. Over-the-counter CGM sensors are wearable devices that track glucose levels in real time without a prescription, enabling users to continuously monitor glucose, understand lifestyle impacts, and manage or prevent diabetes more easily. For instance, in September 2024, Dexcom Inc., a US-based diabetes technology company, launched Stelo, its first OTC CGM patch in the United States. The small, wearable sensor attaches to the back of the upper arm and provides real-time glucose readings directly to a smartphone app without fingersticks. Designed for people with type 2 diabetes not using insulin and those with prediabetes, Stelo delivers personalized insights on how diet, exercise, and sleep affect glucose levels. The device offers up to 15-day wear, waterproofing, spike and pattern detection, and integrates with Dexcom’s glucose sensing technology, making continuous glucose monitoring more accessible and actionable for a wider population.
In January 2024, Trinity Biotech plc, an Ireland-based diagnostics company, acquired the biosensor and CGM assets of Waveform Technologies Inc. for $12.5 million in cash and 9 million ADSs. This acquisition enables Trinity Biotech to enter the growing biosensor and CGM market by leveraging Waveform’s needle-free CGM technology to develop next-generation wearable biosensors, target additional biomarkers, and promote broader global adoption of affordable diabetes care tools. Waveform Technologies Inc. is a US-based company specializing in real-time blood glucose CGM patch technology.
Major companies operating in the real-time blood glucose continuous glucose monitoring (cgm) patch market are Abbott Laboratories, Dexcom Inc., Medtronic plc, Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., MicroTech Medical Inc., Zhejiang POCTech Co. Ltd., SiBio Technology Co. Ltd., Metronom Health Inc., Nemaura Medical Inc., PKvitality SAS, Nutromics Ltd., EOFlow Co. Ltd., i-SENS Inc., Sinocare Inc., Afon Technology Ltd., LifePlus Inc., Ultrahuman Healthcare Pvt. Ltd., Roche Diabetes Care AG, Ascensia Diabetes Care Holdings AG.
North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time blood glucose continuous glucose monitoring (cgm) patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the real-time blood glucose continuous glucose monitoring (cgm) patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have introduced cost pressures and supply chain disruptions in the real-time blood glucose continuous glucose monitoring (CGM) patch market by increasing the prices of electronic components, biosensors, and wireless modules sourced from international suppliers. These cost increases have particularly affected wearable and implantable CGM patch manufacturers, with Asia-Pacific manufacturing hubs such as China and South Korea and high-consumption regions such as North America being most impacted. Distribution channels such as hospital pharmacies and online pharmacies have also faced pricing volatility due to higher import duties. However, tariffs have encouraged regional manufacturing, supplier diversification, and localized production, which is strengthening supply chain resilience and supporting long-term market stability.
The real-time blood glucose continuous glucose monitoring (cgm) patch market research report is one of a series of new reports that provides real-time blood glucose continuous glucose monitoring (cgm) patch market statistics, including real-time blood glucose continuous glucose monitoring (cgm) patch industry global market size, regional shares, competitors with a real-time blood glucose continuous glucose monitoring (cgm) patch market share, detailed real-time blood glucose continuous glucose monitoring (cgm) patch market segments, market trends and opportunities, and any further data you may need to thrive in the real-time blood glucose continuous glucose monitoring (cgm) patch industry. This real-time blood glucose continuous glucose monitoring (cgm) patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A real-time blood glucose continuous glucose monitoring (CGM) patch is a wearable device that continuously monitors glucose levels in the interstitial fluid beneath the skin. It transmits glucose readings in real time to a connected display or mobile device, enabling continuous tracking of glucose trends. The patch functions through a small sensor and transmitter that provide frequent data updates without requiring fingerstick measurements.
The primary product types of real-time blood glucose continuous glucose monitoring (CGM) patches are wearable CGM patches and implantable CGM patches. A wearable CGM patch is a discreet, skin-worn sensor that continuously tracks glucose levels and transmits real-time data to support management of diet, activity, and medication. These patches incorporate various technologies, including enzymatic and non-enzymatic systems, and are distributed through channels such as online pharmacies, retail pharmacies, hospital pharmacies, and other outlets. They are used for applications including type 1 diabetes, type 2 diabetes, gestational diabetes, and other conditions, and are utilized by hospitals, clinics, homecare settings, diagnostic centers, and other end-users.
The real-time blood glucose continuous glucose monitoring (CGM) patch market consists of revenues earned by entities by providing services such as remote patient monitoring and telehealth support, subscription and replacement programs, distribution and logistics management, clinical and diagnostic glucose monitoring services, research and development for sensor innovation, customer training and technical support, and reimbursement or healthcare partnership services. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time blood glucose continuous glucose monitoring (CGM) patch market also includes sales of microneedles paper-type biodegradable sensor, disposable patch sensor, and adhesive-backed sensor. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market Characteristics
3. Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market Supply Chain Analysis
4. Global Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market Trends and Strategies
5. Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market Analysis of End Use Industries
7. Global Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Total Addressable Market (TAM) Analysis for the Market
9. Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market Segmentation
10. Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market Regional and Country Analysis
11. Asia-Pacific Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
12. China Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
13. India Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
14. Japan Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
15. Australia Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
16. Indonesia Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
17. South Korea Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
18. Taiwan Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
19. South East Asia Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
20. Western Europe Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
21. UK Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
22. Germany Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
23. France Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
24. Italy Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
25. Spain Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
26. Eastern Europe Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
27. Russia Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
28. North America Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
29. USA Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
30. Canada Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
31. South America Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
32. Brazil Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
33. Middle East Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
34. Africa Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market
36. Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market Competitive Landscape and Company Profiles
37. Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market Other Major and Innovative Companies
40. Real-Time Blood Glucose Continuous Glucose Monitoring (Cgm) Patch Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses real-time blood glucose continuous glucose monitoring (cgm) patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for real-time blood glucose continuous glucose monitoring (cgm) patch? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The real-time blood glucose continuous glucose monitoring (cgm) patch market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Wearable Continuous Glucose Monitoring (CGM) Patch; Implantable Continuous Glucose Monitoring (CGM) Patch2) By Technology: Enzymatic; Non-Enzymatic
3) By Distribution Channel: Online Pharmacies; Retail Pharmacies; Hospital Pharmacies; Other Distribution Channels
4) By Application: Type 1 Diabetes; Type 2 Diabetes; Gestational Diabetes; Other Applications
5) By End User: Hospitals And Clinics; Homecare Settings; Diagnostic Centers; Other End Users
Subsegments:
1) By Wearable Continuous Glucose Monitoring (CGM) Patch: Sensor-Embedded Wearable Continuous Glucose Monitoring (CGM) Patch; Bluetooth-Enabled Wearable Continuous Glucose Monitoring (CGM) Patch; Mobile-Connected Wearable Continuous Glucose Monitoring (CGM) Patch2) By Implantable Continuous Glucose Monitoring (CGM) Patch: Subcutaneous Implantable Continuous Glucose Monitoring (CGM) Patch; Long-Term Implantable Continuous Glucose Monitoring (CGM) Patch; Miniaturized Implantable Continuous Glucose Monitoring (CGM) Patch
Companies Mentioned: Abbott Laboratories; Dexcom Inc.; Medtronic plc; Senseonics Holdings Inc.; Medtrum Technologies Inc.; Biolinq Inc.; MicroTech Medical Inc.; Zhejiang POCTech Co. Ltd.; SiBio Technology Co. Ltd.; Metronom Health Inc.; Nemaura Medical Inc.; PKvitality SAS; Nutromics Ltd.; EOFlow Co. Ltd.; i-SENS Inc.; Sinocare Inc.; Afon Technology Ltd.; LifePlus Inc.; Ultrahuman Healthcare Pvt. Ltd.; Roche Diabetes Care AG; Ascensia Diabetes Care Holdings AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch market report include:- Abbott Laboratories
- Dexcom Inc.
- Medtronic plc
- Senseonics Holdings Inc.
- Medtrum Technologies Inc.
- Biolinq Inc.
- MicroTech Medical Inc.
- Zhejiang POCTech Co. Ltd.
- SiBio Technology Co. Ltd.
- Metronom Health Inc.
- Nemaura Medical Inc.
- PKvitality SAS
- Nutromics Ltd.
- EOFlow Co. Ltd.
- i-SENS Inc.
- Sinocare Inc.
- Afon Technology Ltd.
- LifePlus Inc.
- Ultrahuman Healthcare Pvt. Ltd.
- Roche Diabetes Care AG
- Ascensia Diabetes Care Holdings AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 8.08 Billion |
| Forecasted Market Value ( USD | $ 13.89 Billion |
| Compound Annual Growth Rate | 14.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
